New Vivus board appoints Zook as CEO

 
• By Mandy Jackson

Former AstraZeneca commercial head Anthony "Tony" Zook was appointed CEO of obesity drug maker Vivus as expected now that the Mountain View, California-based company's largest investor First Manhattan Co (FMC) controls a majority of the Vivus board of directors seats.

More from Alimentary/Metabolic

More from Therapy Areas